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The prototype strain of human echovirus EV 6 (EV6) binds the complement regulator decay
accelerating factor (OAF) with low affinity and, unlike other OAF-binding EVs, cannot haemagglutinate
(HA) red blood cells. Binding to the surface of human rhabdomyosarcoma (RO) cells by EV6 is
primarily mediated by the glycosaminoglycan heparan sulfate (HS). By passaging this virus in the
presence of soluble heparin, a highly sulphated form of HS, we have generated HS binding variant
viruses (HSvarVs) that can mediate haemagglutination via OAF; HA of HSvaVs could be inhibited with
very low concentrations of Pischia-expressed soluble OAF. Affinity chromatography using heparin
agarose columns and binding-inhibition assays with soluble heparin demonstrated that these variants
retained their HS-binding phenotype at levels indistinguishable from the wildtype virus. Sequence
analysis of the region of viral RNA encoding the capsid proteins revealed single amino acid changes in
the EF-Ioop of VP2 for each of the HSvaVs, indicating that molecular determinants for OAF-binding are
likely to reside in this region. An additional HSvaV, which demonstrated no detectable HS-binding
phenotype, was found to have an additional charged amino acid change in the DE loop of VP1, which,
when modelled on the 3D structure of the closely-related EV11, was found to form a ring of charged
residues surrounding the pentameric apex. Interestingly, cell protection assays with an anti-DAF
polyclonal antibody and/or soluble heparin revealed that, regardless of their HS binding phenotype,
infection by prototype or variant viruses was completely blocked only in the presence of antibody,
indicating a requirement of OAF for infection by these viruses. Furthermore, these viruses were shown
to associate with OAF-containing lipid rafts at equivalent levels, supporting the conclusion that, while
the HS-binding phenotype of these viruses may be variable, that of DAF-binding is stable.
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